Covid-19: Enfoque básico para entender sus tratamientos

Carla Cedillo-Alvarez; Itzell A. Gallardo-Ortiz; Luis T. López; Sergio Montes; Nayeli Páez-Martínez

doi:10.24875/GMM.20000452

Covid-19: Enfoque básico para entender sus tratamientos

Translated title of the contribution: Covid-19: A basic approach to understanding potential treatments

Carla Cedillo-Alvarez, Itzell A. Gallardo-Ortiz, Luis T. López, Sergio Montes, Nayeli Páez-Martínez

Escuela Superior de Medicina (ESM)

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral repli-cation, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.

Translated title of the contribution	Covid-19: A basic approach to understanding potential treatments
Original language	Spanish
Pages (from-to)	580-585
Number of pages	6
Journal	Gaceta Medica de Mexico
Volume	156
Issue number	6
DOIs	https://doi.org/10.24875/GMM.20000452
State	Published - 2020

Access to Document

10.24875/GMM.20000452

Cite this

@article{c7dfd840766f4f8b8b9ce5d8a21cac6b,

title = "Covid-19: Enfoque b{\'a}sico para entender sus tratamientos",

abstract = "SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral repli-cation, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.",

keywords = "Covid-19, Pharmacological treatments, Renin-angiotensin system",

author = "Carla Cedillo-Alvarez and Gallardo-Ortiz, {Itzell A.} and L{\'o}pez, {Luis T.} and Sergio Montes and Nayeli P{\'a}ez-Mart{\'i}nez",

note = "Publisher Copyright: {\textcopyright} 2019 Academia Nacional de Medicina de M{\'e}xico, A.C.",

year = "2020",

doi = "10.24875/GMM.20000452",

language = "Espa{\~n}ol",

volume = "156",

pages = "580--585",

journal = "Gaceta Medica de Mexico",

issn = "0016-3813",

number = "6",

}

TY - JOUR

T1 - Covid-19

T2 - Enfoque básico para entender sus tratamientos

AU - Cedillo-Alvarez, Carla

AU - Gallardo-Ortiz, Itzell A.

AU - López, Luis T.

AU - Montes, Sergio

AU - Páez-Martínez, Nayeli

PY - 2020

Y1 - 2020

N2 - SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral repli-cation, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.

AB - SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral repli-cation, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.

KW - Covid-19

KW - Pharmacological treatments

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=85102856086&partnerID=8YFLogxK

U2 - 10.24875/GMM.20000452

DO - 10.24875/GMM.20000452

M3 - Artículo de revisión

C2 - 33877122

AN - SCOPUS:85102856086

SN - 0016-3813

VL - 156

SP - 580

EP - 585

JO - Gaceta Medica de Mexico

JF - Gaceta Medica de Mexico

IS - 6

ER -

Covid-19: Enfoque básico para entender sus tratamientos

Abstract

Access to Document

Other files and links

Fingerprint

Cite this